The FDA has printed overdue draft guidance on establishing variety motion programs for clinical trials, transferring the agency a phase closer into the statutory mandate that all phase 3 trials involve these programs. https://denisqxdz772844.wikipublicity.com/5464783/the_greatest_guide_to_regulatory_affairs_news_blogs